We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.28%
AUM
$130M
AUM Growth
-$25.9M
Cap. Flow
-$4.24M
Cap. Flow %
-3.28%
Top 10 Hldgs %
29.41%
Holding
105
New
1
Increased
11
Reduced
61
Closed
13

Top Sells

Rank Stock Value
1
CPRI icon
Capri Holdings
CPRI
+$2.33M
2
ESRX
Express Scripts Holding Company
ESRX
+$1.72M
3
BA icon
Boeing
BA
+$361K
4
VTRS icon
Viatris
VTRS
+$262K
5
AMZN icon
Amazon
AMZN
+$258K

Sector Composition

Rank Sector Weight
1 Technology 28.48%
2 Healthcare 25.86%
3 Industrials 14.46%
4 Financials 7.13%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$4.49M 3.47%
113,852
-1,952
-2% -$94.6K
MSFT icon
2
Microsoft
MSFT
$2.84T
$4.33M 3.34%
42,609
-1,235
-3% -$132K
NTAP icon
3
NetApp
NTAP
$32.9B
$4.31M 3.33%
72,191
-993
-1% -$71.4K
CHRW icon
4
C.H. Robinson
CHRW
$22B
$4.06M 3.14%
48,317
-696
-1% -$62.3K
CSCO icon
5
Cisco
CSCO
$450B
$3.59M 2.77%
82,829
-2,083
-2% -$95.3K
TROW icon
6
T. Rowe Price
TROW
$25B
$3.57M 2.76%
38,661
+13
+0% +$1.26K
REGN icon
7
Regeneron Pharmaceuticals
REGN
$68.8B
$3.56M 2.75%
9,530
-100
-1% -$36.6K
INFY icon
8
Infosys
INFY
$45B
$3.42M 2.64%
358,857
-2,431
-0.7% -$23.2K
QCOM icon
9
Qualcomm
QCOM
$176B
$3.4M 2.62%
59,704
-685
-1% -$41.6K
GILD icon
10
Gilead Sciences
GILD
$161B
$3.36M 2.6%
53,738
+15,333
+40% +$1.07M
EXPD icon
11
Expeditors International
EXPD
$22.9B
$3.18M 2.46%
46,733
-394
-0.8% -$27.7K
AMGN icon
12
Amgen
AMGN
$203B
$3.18M 2.45%
16,327
-627
-4% -$122K
BEN icon
13
Franklin Resources
BEN
$16.9B
$2.99M 2.31%
100,929
-620
-0.6% -$19.1K
CHKP icon
14
Check Point Software Technologies
CHKP
$13.3B
$2.81M 2.17%
27,390
-100
-0.4% -$11K
CDK
15
DELISTED
CDK Global, Inc.
CDK
$2.68M 2.07%
+55,952
New +$2.95M
FLIR
16
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$2.5M 1.93%
57,376
-595
-1% -$29.3K
IBM icon
17
IBM
IBM
$202B
$2.44M 1.89%
22,491
-675
-3% -$81K
CELG
18
DELISTED
Celgene Corp
CELG
$2.43M 1.88%
37,945
+4,310
+13% +$318K
DLB icon
19
Dolby
DLB
$4.72B
$2.25M 1.73%
36,320
-299
-0.8% -$20.1K
CI icon
20
Cigna
CI
$76.6B
$2.21M 1.71%
11,665
+3,565
+44% +$744K
JNJ icon
21
Johnson & Johnson
JNJ
$635B
$2.12M 1.63%
16,390
-1,498
-8% -$209K
UNH icon
22
UnitedHealth
UNH
$382B
$2.01M 1.55%
8,067
-150
-2% -$39.6K
TEVA icon
23
Teva Pharmaceuticals
TEVA
$35.9B
$1.97M 1.52%
127,795
-2,300
-2% -$47.2K
URBN icon
24
Urban Outfitters
URBN
$5.99B
$1.97M 1.52%
59,356
-600
-1% -$22.4K
KSS icon
25
Kohl's
KSS
$2.03B
$1.97M 1.52%
29,664
-294
-1% -$20.6K

Similar funds

AIMZ Investment Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, AIMZ Investment Advisors held 105 positions worth $130M, down 17% from $155M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

AIMZ Investment Advisors withdrew a net $4.24M in Q4 2018, closing 13 positions and reducing 61 holdings. Its most notable exit was Capri Holdings, an estimated $2.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AIMZ Investment Advisors opened a new position in CDK Global, Inc. worth $2.68M.

  • AIMZ Investment Advisors's largest Q4 2018 buy was CDK Global, Inc.: 55,952 shares worth $2.68M.
  • AIMZ Investment Advisors added most to Gilead Sciences in Q4 2018, an estimated $1.07M increase.
  • AIMZ Investment Advisors's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $209K.
  • AIMZ Investment Advisors fully exited Capri Holdings in Q4 2018, selling an estimated $2.33M.
  • AIMZ Investment Advisors's ten largest holdings make up 29% of its $130M portfolio in Q4 2018.
  • AIMZ Investment Advisors opened 1 new position and closed 13 in Q4 2018.
  • AIMZ Investment Advisors's portfolio value fell 17% quarter-over-quarter to $130M.

Based on AIMZ Investment Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.